Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
✍ Scribed by Gianluigi Mazzoccoli; Incoronata Notarsanto; Gennaro Davide de Pinto; Mariangela Pia Dagostino; Angelo De Cata; Giuseppe D’Alessandro; Roberto Tarquini; Gianluigi Vendemiale
- Book ID
- 107481446
- Publisher
- Springer Milan
- Year
- 2010
- Tongue
- English
- Weight
- 208 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1828-0447
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana
COPD ϭ chronic obstructive pulmonary disease. 300 Letters \* RA ϭ rheumatoid arthritis; JRA ϭ juvenile rheumatoid arthritis; ESR ϭ erythrocyte sedimentation rate; CRP ϭ C-reactive protein; VAS ϭ visual analog scale; GH ϭ general health; DAS28 ϭ Disease Activity Score in 28 joints; HAQ ϭ Health Asses
## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif